Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, GLOBUS MEDICAL, INC. reported revenue of $2.94B, up 16.7% year over year. Operating margin was 16.3% and net margin 18.3%, on a free-cash-flow margin of 20.0% with capital expenditure at 5.6% of revenue. Every figure is computed directly from GMED's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $2.94B | 16.3% | 18.3% |
| FY2024 | $2.52B | 6.6% | 4.1% |
| FY2023 | $1.57B | 8.5% | 7.8% |
| FY2022 | $1.02B | 22.3% | 18.6% |
| FY2021 | $958M | 17.9% | 15.6% |
How does GMED compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.